The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
8-(2-Furyl)-2-[2-(1-hydroxycyclohexyl)ethyn-1-yl]-N9-propargyladenine ID: ALA3291310
PubChem CID: 89805044
Max Phase: Preclinical
Molecular Formula: C20H19N5O2
Molecular Weight: 361.41
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: C#CCn1c(-c2ccco2)nc2c(N)nc(C#CC3(O)CCCCC3)nc21
Standard InChI: InChI=1S/C20H19N5O2/c1-2-12-25-18(14-7-6-13-27-14)24-16-17(21)22-15(23-19(16)25)8-11-20(26)9-4-3-5-10-20/h1,6-7,13,26H,3-5,9-10,12H2,(H2,21,22,23)
Standard InChI Key: GTGGDWUGNLGPSN-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
12.6656 -13.2594 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2460 -13.9617 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6423 -14.6723 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4597 -14.6868 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8793 -13.9844 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4815 -13.2676 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5194 -11.2187 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.5204 -12.0373 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8070 -12.4470 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.1043 -12.0360 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1027 -11.2195 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8084 -10.8119 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8110 -9.9953 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.3291 -12.2916 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.8477 -11.6247 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3263 -10.9686 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.0741 -13.0680 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2812 -13.2439 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4779 -13.4152 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2314 -12.4483 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9465 -12.8552 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0803 -12.5604 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.0314 -11.6245 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5527 -10.9622 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.7749 -11.2128 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7729 -12.0300 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5494 -12.2844 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 6 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 1 0
7 12 2 0
10 14 1 0
14 15 1 0
15 16 2 0
11 16 1 0
17 18 1 0
18 19 3 0
14 17 1 0
20 21 3 0
21 1 1 0
1 22 1 0
8 20 1 0
23 24 1 0
24 25 1 0
25 26 2 0
26 27 1 0
27 23 2 0
15 23 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 361.41Molecular Weight (Monoisotopic): 361.1539AlogP: 2.35#Rotatable Bonds: 2Polar Surface Area: 102.99Molecular Species: NEUTRALHBA: 7HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.97CX Basic pKa: 3.77CX LogP: 2.98CX LogD: 2.98Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.68Np Likeness Score: -0.79
References 1. Endo K, Deguchi K, Matsunaga H, Tomaya K, Yamada K.. (2014) 8-Substituted 2-alkynyl-N(9)-propargyladenines as A2A adenosine receptor antagonists., 22 (12): [PMID:24815000 ] [10.1016/j.bmc.2014.04.041 ]